576 - 600 of 9030 Results
Title
Year
- Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?2023RESTRICTEDTitle: Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2023.1197853Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2023.1197853/pdfCitation Count: 5
-
RESTRICTEDTitle: Small Molecules to Improve ER Proteostasis in DiseaseJournal Name: Trends in Pharmacological SciencesPublisher: Elsevier BVVol: 40Issue #: 9Start Page: 684End Page: 695Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.tips.2019.07.003Best OA location URL: http://manuscript.elsevier.com/S0165614719301403/pdf/S0165614719301403.pdfCitation Count: 63
-
RESTRICTEDTitle: Clinical neurophysiology of Parkinson’s disease and parkinsonismJournal Name: Clinical Neurophysiology PracticePublisher: Elsevier BVVol: 7Issue #:Start Page: 201End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cnp.2022.06.002Best OA location URL: https://doi.org/10.1016/j.cnp.2022.06.002Citation Count: 33
- Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’s2014RESTRICTEDTitle: Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’sJournal Name:Publisher:Vol:Issue #:Start Page: 22End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.14524/cr-13-00066r1.1Citation Count: 1
-
RESTRICTEDTitle: Addition to “Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders”Journal Name: ACS Applied Materials & InterfacesPublisher: American Chemical Society (ACS)Vol: 15Issue #: 10Start Page: 13824End Page: 13824Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acsami.3c02300Best OA location URL: https://doi.org/10.1021/acsami.3c02300Citation Count: 0
-
RESTRICTEDTitle: Novel therapeutic approaches to target neurodegenerationJournal Name: British Journal of PharmacologyPublisher: WileyVol: 180Issue #: 13Start Page: 1651End Page: 1673Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/bph.16078Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.16078Citation Count: 7
- Huntington disease: A quarter century of progress since the gene discovery2019RESTRICTEDTitle: Huntington disease: A quarter century of progress since the gene discoveryJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 396Issue #:Start Page: 52End Page: 68Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2018.09.022Citation Count: 59
- REM Sleep Behavior and Motor Findings in Parkinson's Disease: A Cross-sectional Analysis.2014RESTRICTEDTitle: REM Sleep Behavior and Motor Findings in Parkinson's Disease: A Cross-sectional Analysis.Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.7916/d84b2zdfCitation Count: 4
- Juvenile parkinsonism: Differential diagnosis, genetics, and treatment2019RESTRICTEDTitle: Juvenile parkinsonism: Differential diagnosis, genetics, and treatmentJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 67Issue #:Start Page: 74End Page: 89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.025Citation Count: 67
-
RESTRICTEDTitle: Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeuticsJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 119Issue #: 1Start Page: 39End Page: 52Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s00702-011-0682-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-011-0682-x.pdfCitation Count: 68
-
RESTRICTEDTitle: Digital technologies: Innovations that transform the face of drug developmentJournal Name: Clinical and Translational SciencePublisher: WileyVol: 16Issue #: 8Start Page: 1323End Page: 1330Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cts.13533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13533Citation Count: 2
- Serotonergic Approaches in Parkinson’s Disease: Translational Perspectives, an Update2017RESTRICTEDTitle: Serotonergic Approaches in Parkinson’s Disease: Translational Perspectives, an UpdateJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 8Issue #: 5Start Page: 973End Page: 986Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00440Citation Count: 34
-
RESTRICTEDTitle: Unmet needs in Parkinson disease: Motor and non-motorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: S7End Page: S12Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.024Best OA location URL: http://www.prd-journal.com/article/S1353802020307380/pdfCitation Count: 60
- Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology.2021RESTRICTEDTitle: Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology.Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.17879/freeneuropathology-2021-3326Citation Count: 7
- γ‐Synuclein and the progression of cancer2007RESTRICTEDTitle: γ‐Synuclein and the progression of cancerJournal Name: The FASEB JournalPublisher: WileyVol: 21Issue #: 13Start Page: 3419End Page: 3430Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.07-8379revCitation Count: 91
-
RESTRICTEDTitle: Clinical and Imaging Markers of Prodromal Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00395Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00395/pdfCitation Count: 91
- Suspected non-Alzheimer's pathology – Is it non-Alzheimer's or non-amyloid?2017RESTRICTEDTitle: Suspected non-Alzheimer's pathology – Is it non-Alzheimer's or non-amyloid?Journal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 36Issue #:Start Page: 20End Page: 31Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2017.02.003Citation Count: 33
-
RESTRICTEDTitle: Harnessing ionic mechanisms to achieve disease modification in neurodegenerative disordersJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 147Issue #:Start Page: 104343End Page: 104343Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2019.104343Best OA location URL: https://flore.unifi.it/bitstream/2158/1175329/1/2019%20Harnessing%20ion%20channel.pdfCitation Count: 7
-
RESTRICTEDTitle: Striatal cholinergic interneurons and Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 47Issue #: 10Start Page: 1148End Page: 1158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.13638Best OA location URL: https://europepmc.org/articles/pmc6074051?pdf=renderCitation Count: 70
-
RESTRICTEDTitle: Blood-based biomarkers for Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #:Start Page: S99End Page: S103Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1353-8020(13)70025-7Best OA location URL: https://europepmc.org/articles/pmc4070332?pdf=renderCitation Count: 123
-
RESTRICTEDTitle: Biomarkers in Parkinson's disease: Advances and strategiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S106End Page: S110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.048Best OA location URL: https://europepmc.org/articles/pmc5120398?pdf=renderCitation Count: 133
-
RESTRICTEDTitle: Oxidized DJ-1 as a possible biomarker of Parkinson’s diseaseJournal Name: Journal of Clinical Biochemistry and NutritionPublisher: The Society for Free Radical Research JapanVol: 54Issue #: 3Start Page: 138End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3164/jcbn.13-108Best OA location URL: https://www.jstage.jst.go.jp/article/jcbn/54/3/54_13-108/_pdfCitation Count: 61
- Leucine‐rich repeat kinase 2 and Parkinson's disease2016RESTRICTEDTitle: Leucine‐rich repeat kinase 2 and Parkinson's diseaseJournal Name: PROTEOMICSPublisher: WileyVol: 17Issue #: 1-2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/pmic.201600092Citation Count: 23
- Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synuclein2016RESTRICTEDTitle: Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synucleinJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 42Issue #: 1Start Page: 51End Page: 76Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/nan.12299Citation Count: 66
-
RESTRICTEDTitle: Intersection of immunometabolism and immunosenescence during agingJournal Name: Current Opinion in PharmacologyPublisher: Elsevier BVVol: 57Issue #:Start Page: 107End Page: 116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.coph.2021.01.003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481958Citation Count: 21